Trials / Recruiting
RecruitingNCT05760391
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
A Trial of Combination and Timing of Immunotherapy With Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-arm, prospective, phase II trial for patients with metastatic esophageal squamous cell carcinoma (ESCC) who received immunotherapy plus chemotherapy as the first-line treatment. The aim of the study is to determine if intervening with combined local therapy and immunotherapy and chemotherapy in patients with ESCC led to significant improvements in survival and disease control compared with historical data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy | IMRT or SABR for patients with ESCC. |
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2025-02-01
- Completion
- 2026-08-01
- First posted
- 2023-03-08
- Last updated
- 2023-07-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05760391. Inclusion in this directory is not an endorsement.